One of the stories that has stood out over the last few years in breast cancer treatment was the FDA’s approval in 2015 of the drug palbociclib (Ibrance) for treatment of hormone receptor-positive metastatic breast cancer.
This year, there have been several new developments in targeted therapies for hormone-receptor positive breast cancer. Continue reading
I’m delighted to participate in the 2019 Summer Blogging Challenge offered by my friend and fellow blogger, Nancy, at Nancy’s Point.
The challenge involves answering a series of random questions about ourselves and blogging. Continue reading
What are the best ideas for how we could prevent breast cancer in whole populations?
This was the big question behind a recent competition sponsored by the California Breast Cancer Research Program. Continue reading
One of my first posts here on After Twenty Years in 2013 was a look back at progress against breast cancer in the twenty years since I had been diagnosed.
Now, let’s take another look back, but this time we’ll focus on what we’ve seen in progress against breast cancer over the last five years or so. Continue reading
Earlier this month, the long-awaited results of the TAILORx clinical trial were announced.
The findings from this study are important for early stage breast cancer patients with hormone receptor-positive breast cancer. The study results are expected to assist many patients in this group in determining whether chemotherapy should be part of their treatment. Continue reading
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this spring.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
A recent article in the New York Times reported on the stories of a number of individuals struggling to cope with drug prices for essential medications that are far beyond what they can afford.
Dr. Elisabeth Rosenthal, in her book “An American Sickness” gives us some perspective on how we got to where we are today with healthcare costs in this country and what we can do about it. Continue reading
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this winter.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
What’s the latest “need to know” news in cancer research? In this post, I’ll briefly review several of the most interesting cancer research stories that have been in the news this fall.
These are a few of the recent stories that seem to have the greatest potential impact, at least from my perspective, and that I know I’ll want to follow as they develop further. Continue reading
Earlier this year I made the decision to undergo genetic testing to find out whether I’ve inherited any genetic mutation that could increase my risk for a new breast cancer diagnosis or for other cancers.
I was diagnosed with breast cancer when I was only in my mid-thirties. But that was in 1993 and, for a number of reasons, including having no family history of breast or ovarian cancer, I’ve never had genetic testing before.
Here’s what the experience was like for me and some of the helpful things I learned in the process. Continue reading
